Table 3.
The pharmacokinetic properties prediction by SwissADME software.
| Ligand | GI absorption | Cytochrome inhibitor | Bioavailability | ||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |||
| b | High | Yes | Yes | Yes | Yes | No | 0.85 |
| c | Low | Yes | Yes | No | Yes | Yes | 0.55 |
| 9ІV-c | Low | NO | Yes | Yes | No | No | 0.55 |
1: CYP1A2; 2: CYP2C19; 3: CYP2C9; 4: CYP2D6; 5: CYP3A4.